Equity Profile

ICLR

ICON Public Limited Company

Health CareLife Sciences Tools & Services$11.4B

May28Thu

Pre-Earnings Brief

UpcomingQ1-2026After Close5:00 PM EDT

Company Snapshot

ICON Public Limited Company operates in the health care sector, specifically in life sciences tools and services. The company plays a crucial role in supporting the development of new drugs and medical devices, which is vital for innovation in health care and improving patient outcomes.

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.

N/A

Revenue Growth

Revenue growth reflects the company's ability to expand its business and capture market share in the life sciences sector.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

ICLR Q1-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+3.12%

Avg Stock Reaction

+1.30%

Last Quarter Recap

In the last quarter, ICON reported an EPS of $2.52, which did not have an analyst estimate for comparison. The stock reacted positively, gaining 4.04% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Overall expectations for ICON's upcoming earnings are mixed, with no analyst estimates available to guide sentiment. Investors will be looking for any signs of continued growth or challenges in the life sciences market.

Bull Case

An optimistic view hinges on the company's strong historical EPS performance, with an 86% beat rate over the last eight quarters, suggesting potential for another positive surprise.

Bear Case

On the other hand, without clear guidance or estimates, there is a risk that any unexpected challenges could lead to a negative market reaction, especially if the company fails to meet historical performance.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will be the EPS for Q1-2026?

Given the company's strong historical performance, any significant deviation from expected EPS could heavily influence market sentiment.

How is revenue growth trending in the current market environment?

Understanding revenue growth is crucial as it reflects the company's ability to navigate challenges and capitalize on opportunities in the life sciences sector.

Edge

What the Street Is Missing

Why consensus could be wrong

The market may be underestimating ICON's ability to maintain its growth trajectory despite current uncertainties in the life sciences sector.

Supporting Evidence

The company has consistently beaten EPS estimates, suggesting strong operational management.

Options pricing indicates a higher expected move than historical averages, reflecting uncertainty that could work in ICON's favor.

The lack of analyst estimates could mean that the market is not fully accounting for ICON's potential upside.

Key Risk

If the company reports an EPS significantly above $3.00, it could challenge the current cautious sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is particularly important as it will set the tone for investor confidence in ICON's growth trajectory.

Bull Confirmed If

A reported EPS above $3.00 would confirm the bull case, indicating strong profitability.

Bear Confirmed If

An EPS below $2.50 would confirm the bear case, suggesting potential operational or market challenges.

Pre-Earnings Positioning

Options Market

Implied Move

±2.09%

Historical Avg

±1.66%

Pricing rich

The options market is pricing in a move of about 2.09%, indicating some uncertainty around the earnings report.

Options are pricing a larger move than the stock has averaged historically, suggesting heightened expectations.

Detail

ATM IV

0.6%

30d HV

74.0%

Calls (174K)P/C Ratio: 0.19Puts (149K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 13 of 29 (45%)

This setup has occurred 30 times across Health Care in the last 2 years. 13 of 29 faded and 16 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 5.5%, with a raw directional average of +2.9% (modestly positive historical bias).

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If ICON beats expectations, history suggests a potential stock increase of around 1.22%, confirming the company's strong growth narrative.

In-Line / Cautious

If results are in line with expectations, the stock may see a muted reaction as investors await further guidance.

Miss

If ICON misses expectations, history suggests a potential decline of around 0.96%, which could raise concerns about future growth prospects.

Preparation

Congressional Activity

House & Senate STOCK Act disclosures over the trailing 6 months.

Trades

0 buys·2 sells

Members

House only

Est. Notional

$101,002.00–$265,000.00

disclosed dollar ranges

Most Active Members

R-OKKevin HernRep.
1

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new contracts or partnerships that could drive revenue growth.
2Details on cost management strategies and their impact on margins.
3Insights into market trends affecting the life sciences sector.
4Any commentary on competitive positioning within the industry.
5Management's outlook on future growth opportunities and challenges.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

JOYY Inc.

Company Snapshot

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.

N/A

Revenue Growth

Revenue growth reflects the company's ability to expand its business and capture market share in the life sciences sector.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

ICLR Q1-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+3.12%

Avg Stock Reaction

+1.30%

Last Quarter Recap

In the last quarter, ICON reported an EPS of $2.52, which did not have an analyst estimate for comparison. The stock reacted positively, gaining 4.04% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Bull Case

An optimistic view hinges on the company's strong historical EPS performance, with an 86% beat rate over the last eight quarters, suggesting potential for another positive surprise.

Bear Case

Expectations

Two Questions That Matter

The print will turn on these two things.

What will be the EPS for Q1-2026?

Given the company's strong historical performance, any significant deviation from expected EPS could heavily influence market sentiment.

How is revenue growth trending in the current market environment?

Understanding revenue growth is crucial as it reflects the company's ability to navigate challenges and capitalize on opportunities in the life sciences sector.

Edge

What the Street Is Missing

Why consensus could be wrong

The market may be underestimating ICON's ability to maintain its growth trajectory despite current uncertainties in the life sciences sector.

Supporting Evidence

The company has consistently beaten EPS estimates, suggesting strong operational management.

Options pricing indicates a higher expected move than historical averages, reflecting uncertainty that could work in ICON's favor.

The lack of analyst estimates could mean that the market is not fully accounting for ICON's potential upside.

Key Risk

If the company reports an EPS significantly above $3.00, it could challenge the current cautious sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is particularly important as it will set the tone for investor confidence in ICON's growth trajectory.

Bull Confirmed If

A reported EPS above $3.00 would confirm the bull case, indicating strong profitability.

Bear Confirmed If

An EPS below $2.50 would confirm the bear case, suggesting potential operational or market challenges.

Pre-Earnings Positioning

Options Market

Implied Move

±2.09%

Historical Avg

±1.66%

Pricing rich

The options market is pricing in a move of about 2.09%, indicating some uncertainty around the earnings report.

Options are pricing a larger move than the stock has averaged historically, suggesting heightened expectations.

Detail

ATM IV

0.6%

30d HV

74.0%

Calls (174K)P/C Ratio: 0.19Puts (149K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 13 of 29 (45%)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If ICON beats expectations, history suggests a potential stock increase of around 1.22%, confirming the company's strong growth narrative.

In-Line / Cautious

If results are in line with expectations, the stock may see a muted reaction as investors await further guidance.

Miss

If ICON misses expectations, history suggests a potential decline of around 0.96%, which could raise concerns about future growth prospects.

Preparation

Congressional Activity

House & Senate STOCK Act disclosures over the trailing 6 months.

Trades

0 buys·2 sells

Members

House only

Est. Notional

$101,002.00–$265,000.00

disclosed dollar ranges

Most Active Members

R-OKKevin HernRep.
1

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new contracts or partnerships that could drive revenue growth.
2Details on cost management strategies and their impact on margins.
3Insights into market trends affecting the life sciences sector.
4Any commentary on competitive positioning within the industry.
5Management's outlook on future growth opportunities and challenges.